These medicines include semaglutide (Ozempic, Wegovy, Rybelsus), liraglutide (Victoza, Saxenda), dulaglutide (Trulicity), and tirzepatide (Mounjaro), which is a dual GIP/GLP-1 receptor agonist rather than a pure GLP-1 agonist
Note: All cited studies refer to in-vitro and animal model research
Pregnant and breastfeeding women should avoid the peptide due to unknown effects on fetal and infant development
Growth hormone release is closely coupled to slow-wave sleep, and the broader GHRH literature demonstrates that GHRH signaling can influence sleep-endocrine activity, particularly non-REM and slow-wave sleep parameters in controlled experimental settings [5]
Our Melanotan-II 10mg is verified at 99.30% purity by reversed-phase HPLC